Research Analysts’ Recent Ratings Changes for Davita (DVA)

Several brokerages have updated their recommendations and price targets on shares of Davita (NYSE: DVA) in the last few weeks:

  • 1/9/2019 – Davita had its “hold” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $65.00 price target on the stock.
  • 1/8/2019 – Davita was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $59.00 price target on the stock, down previously from $64.00.
  • 1/3/2019 – Davita is now covered by analysts at Deutsche Bank AG. They set a “buy” rating and a $60.00 price target on the stock.
  • 1/2/2019 – Davita was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.
  • 12/14/2018 – Davita is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $70.00 price target on the stock.
  • 12/2/2018 – Davita was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating. They now have a $63.44 price target on the stock.
  • 11/28/2018 – Davita was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $70.00 price target on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 11/15/2018 – Davita is now covered by analysts at UBS Group AG. They set a “sell” rating and a $64.00 price target on the stock.

Shares of NYSE DVA opened at $56.07 on Monday. The company has a debt-to-equity ratio of 2.09, a current ratio of 1.84 and a quick ratio of 1.82. The firm has a market capitalization of $8.95 billion, a P/E ratio of 16.89, a PEG ratio of 0.54 and a beta of 1.25. Davita Inc has a one year low of $48.25 and a one year high of $80.03.

Davita (NYSE:DVA) last announced its quarterly earnings results on Wednesday, November 7th. The company reported $0.56 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.33). Davita had a net margin of 5.39% and a return on equity of 13.87%. The company had revenue of $2.85 billion during the quarter, compared to the consensus estimate of $2.93 billion. During the same quarter last year, the company earned $0.81 earnings per share. The business’s revenue was up 3.0% on a year-over-year basis. Equities analysts anticipate that Davita Inc will post 3.56 EPS for the current year.

Large investors have recently made changes to their positions in the business. California Public Employees Retirement System grew its position in Davita by 8.6% in the second quarter. California Public Employees Retirement System now owns 571,830 shares of the company’s stock valued at $39,708,000 after acquiring an additional 45,102 shares during the period. Zeke Capital Advisors LLC acquired a new position in shares of Davita during the third quarter valued at $359,000. Private Advisor Group LLC acquired a new position in shares of Davita during the third quarter valued at $249,000. Raymond James & Associates lifted its stake in shares of Davita by 12.3% during the second quarter. Raymond James & Associates now owns 106,072 shares of the company’s stock valued at $7,366,000 after acquiring an additional 11,637 shares during the period. Finally, Sowell Financial Services LLC acquired a new position in Davita in the third quarter valued at about $1,934,000. Hedge funds and other institutional investors own 85.66% of the company’s stock.

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Article: What are CEFs?

Receive News & Ratings for Davita Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply